United States · Investor

De Novo Ventures

Last cheque observed Jun 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BVentureSeries DInformation ServicesSocial MediaVenture Capital & Private Equity

Cheques on record
0%of best year0cheques in 12 months, 72 on record
Since the last cheque4513days00hrs00min00sec
Median round$20MRounds led0 of 72Sole investor4 roundsExits6 from the portfolioMostly inUnited States, 100%
Pitch De Novo Ventures

De Novo Ventures highlights

  1. 01

    72 rounds on record

  2. 02

    Mostly Series B and Venture: 48% of its rounds

  3. 03

    Sole investor in 4 rounds, median $9.2M

  4. 04

    6 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
Information ServicesSocial MediaVenture Capital & Private Equity
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first72 appearances

  1. 2014

    3 rounds

  2. Jun
    Benvenue MedicalSeries E · US$40MWith 4 others
  3. Jun
    Spinal KineticsVenture · US$34MWith 4 others
  4. May
    EndoGastric SolutionsSeries G · US$30MWith 6 others
  5. 2013

    2 rounds

  6. Jul
    TRIA BeautyGrowth · US · pevc.dowjones.com$46MWith 6 others
  7. Mar
    AvedroSeries D · US · boston.com$43MWith 7 others
  8. 2012

    11 rounds

  9. Dec
    AllakosVenture · US · sec.gov$10.0MWith 4 others
  10. Oct
    TRIA BeautyVenture · US$7.5MWith 3 others
  11. Jun
    Benvenue MedicalSeries D · US · sacbee.com$25MWith 3 others
  12. Jun
    EndoGastric SolutionsSeries F · US · finsmes.com$13MWith 6 others
  13. Jun
    Astute MedicalSeries C · US · finsmes.com$40MWith 5 others
  14. Apr
    WaveTec VisionVenture · US · pevc.dowjones.com$17MWith 2 others
  15. Apr
    EndoGastric SolutionsVenture · US$2.1MWith 6 others
  16. Mar
    MyoScienceSeries D · US · finsmes.com$33MWith 4 others
  17. Mar
    HemaQuest PharmaceuticalsSeries B · US · hemaquest.com$13MWith 4 others
  18. Jan
    PulmonxGrowth · US · researchviews.com$10MWith 4 others
  19. Jan
    iScience InterventionalVenture · US · researchviews.com$2.8MWith 5 others
  20. 2011

    7 rounds

  21. Sept
    Simpirica SpineSeries C · US · finsmes.com$22MWith 2 others
  22. Jun
    Spinal ModulationSeries D · US · businesswire.com$30MWith 7 others
  23. May
    WaveTec VisionSeries D · US · finsmes.com$16MWith 3 others
  24. Apr
    Benvenue MedicalSeries C · US · bizjournals.com$36MWith 3 others
  25. Mar
    Astute MedicalSeries B · US · money.msn.com$13MWith 3 others
  26. Feb
    TRIA BeautyVenture · US$26MWith 3 others
  27. Feb
    SpiracurVenture · US · finsmes.com$35MWith 4 others
  28. 2010

    7 rounds

  29. Sept
    TRIA BeautyVenture · US · finsmes.com$16MWith 3 others
  30. Aug
    EndoGastric SolutionsSeries F · US · endogastricsolutions.com$30MWith 2 others
  31. May
    Astute MedicalSeries B · US · onbiovc.com$27MWith 3 others
  32. May
    TearScienceSeries C · US · onbiovc.com$45MWith 5 others
  33. Apr
    HemaQuest PharmaceuticalsSeries B · US · fiercebiotech.com$12MWith 3 others
  34. Mar
    PulmonxSeries C · US · onbiovc.com$32MWith 6 others
  35. Jan
    EndoGastric SolutionsSeries E · US · onbiovc.com$22MWith 5 others
  36. 2009

    8 rounds

  37. Nov
    Spinal ModulationSeries C · US · deals.venturebeat.com$27MWith 6 others
  38. Nov
    Facet SolutionsSeries C · US · masshightech.com$3.6MWith 2 others
  39. Oct
    EndoGastric SolutionsVenture · US · xconomy.com$9.5MWith 5 others
  40. Jun
    EndoGastric SolutionsVenture · US · xconomy.com$3.8MWith 4 others
  41. Jun
    SpiracurSeries B · US · onbiovc.com$20MWith 2 others
  42. Jun
    Facet SolutionsDebt · US$4.1MWith 2 others
  43. May
    PhotoTheraSeries D · US · onbiovc.com$50MWith 4 others
  44. May
    iScience InterventionalSeries F · US · onbiovc.com$21MWith 7 others
  45. 2008

    8 rounds

  46. Nov
    OncoMed PharmaceuticalsSeries B · US · biospace.com$154MWith 8 others
  47. Jul
    Sierra SurgicalSeries B · US · deals.venturebeat.com$15MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

WaveTec VisionBought by AlconUndisclosedSept 2014
OncoMed PharmaceuticalsListed$82MJul 2013
InSound MedicalBought by Sonova HoldingUndisclosedJan 2010
Bacchus VascularBought by CovidienUndisclosedMar 2009
FlowMedicaBought by AngioDynamicsUndisclosedJan 2009
LumendBought by CordisUndisclosedSept 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as De Novo Ventures. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about De Novo Ventures

What does De Novo Ventures invest in?

De Novo Ventures invests most often at Series B and Venture (48% of the rounds on record), in sectors such as Information Services, Social Media and Venture Capital & Private Equity.

How active is De Novo Ventures?

72 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2014.

How big are De Novo Ventures's cheques?

The median round it joins is $20M.

Does De Novo Ventures lead rounds?

Rarely, if at all: none of its 72 investments on record names it as the lead.

Where does De Novo Ventures invest?

Most of the companies it backs are in the United States (100%).

Is De Novo Ventures investing now?

No investments in the last 12 months; the latest was in Jun 2014.

Who does De Novo Ventures invest alongside?

Most often Delphi Ventures (8 rounds together), Johnson & Johnson Development Corporation (JJDC) (8 rounds together) and Latterell Venture Partners (8 rounds together).

What kind of investor is De Novo Ventures?

De Novo Ventures is a growth equity firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it